Neurovascular Interventions - Global Analysis and Market Forecasts, New Report Launched

Combined, the US, five European Union countries (5EU) (France, Germany, Italy, Spain, and UK), and Japan, account for approximately 80% of the neurointerventional market for cerebrovascular applications. The US is forecast to have the largest market share in the market, followed by Japan, and then collectively, the 5EU. Innovative technologies such as flow diverters and stent retrievers have not received regulatory approval and been launched in the Japanese market. Stent retrievers and flow diverters are expected to enter Japan beginning in 2015.

Key Drivers in the Global Neurovascular Interventions Market

The key drivers for this market during the forecast period are:

• The rising prevalence of cerebrovascular disease and its associated risk factors in the major markets.
• The need for effective therapies that reduce the risk of hemorrhagic and stroke complications, and ensure long-term, reliable outcomes.
• The increased use of remodeling techniques such as stent-assisted and balloon-assisted coiling, and the adoption of flow diverters for the treatment of challenging/complex aneurysms (wide-neck, large, and giant aneurysms).
• The cost savings for healthcare payers resulting from the reduced need for repeat procedures.
• The increase in patients' disposable income and government insurance coverage in the emerging markets, such as China and India.
• The approval and launch of the next-generation of innovative embolization, revascularization, and mechanical thrombectomy devices in the US and Japan.

Physicians believe flow diverters are innovative technologies that will be adopted for challenging intracranial aneurysms in the future. However, they question widespread adoption given the complications/challenges associated with flow diversion devices.

"With flow diverters, there remain major concerns with increased risks compared to alternative strategies. There is the risk of bleeding with dual antiplatelet therapy as opposed to using a strategy that does not require it, such as balloon-assisted coiling or an intra-aneurysm flow disrupter . . . . The overall risks look to be up to . . . % for flow diversion treatment versus approximately . . . % with stent-assisted coiling and . . . % with non-stent-assisted coiling.

Reasons to Buy

• Overview of cerebrovascular disease, including epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities
• Annualized total neurovascular interventions market revenue by device segment, annual cost of disease and neurointerventional devices adoption pattern and procedure data from 2011-2013 and forecast to 2020
• Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the neurovascular interventions market
• Pipeline analysis: comprehensive data split across different stages of development, emerging trends and device designs in development
• Analysis of the current and future market competition in the global neurovascular interventions market. Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Know more about this report at – http://mrr.cm/ZDd

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices